Work

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

Year: 2009

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-009-9220-1

Authors: Lida Mina, Ian Krop, Robin T. Zon, Steven J. Isakoff, Charles J. Schneider, Menggang Yu, Cindy Johnson, LaTrice G. Vaughn, Yanping Wang, Maria Hristova-Kazmierski, Oluwatoyin O. Shonukan, George W. Sledge, Kathy D. Miller

Institutions: Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Dana-Farber Cancer Institute, Northern Indiana Cancer Research Consortium, Massachusetts General Hospital, Eli Lilly (United States)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2096515375

FWCI: 0.874

Cites: 24

Cited by: 31

Related to: 10